Per Johan Nilsson

15PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 18, 2026
A first-in-human, phase I/IIa trial of the T cell immunotherapy personalised tumour trained lymphocytes in patients with advanced colorectal cancer: Study protocol.

|Feb 19, 2026
Locoregional and systemic control after total neoadjuvant therapy with short-course radiotherapy for locally advanced rectal cancer: long-term outcomes from the LARCT-US study.

Israa Imam, Per J Nilsson, Tanweera Khan

|Oct 03, 2025
Short-term morbidity and mortality following surgical treatment of anal squamous cell carcinoma in Sweden - A national multicentre study.

Stephanie Jacobsen, Eva Angenete, Anders Johnsson

|Sep 29, 2025
Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial.

Ilaria Prata, Max D Tanaka, Bengt Glimelius

|Jun 09, 2025
Impact of perineal healing on oncological outcome following surgery for squamous cell carcinoma of the anus.

Naseer Baloch, A Kiasat, Mikael Machado

|Oct 28, 2024
Risks of Organ Preservation in Rectal Cancer: Data From Two International Registries on Rectal Cancer.

Laura M Fernandez, Guilherme P São Julião, Carlos Cerdan Santacruz

Pageof 3

Frequent Collaborators

4 joint publications

Eva Angenete

2 joint publications

Anna Axelsson

2 joint publications

Eva Haglind

1 joint publications

Lisen Båverud Olsson